Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Wet Age-Related Macular Degeneration Clinical Trials
Wet Age-Related Macular Degeneration clinical trials are recruiting across 4 cities. Here are the cities with the most active studies:
Wet Age-Related Macular Degeneration Trial Phases
1 research organizations are sponsoring wet age-related macular degeneration trials.
About Wet Age-Related Macular Degeneration
Wet age-related macular degeneration is the advanced form of AMD where abnormal blood vessels grow under the retina and leak fluid or blood. It can cause rapid vision loss if untreated. Treatment involves regular anti-VEGF injections that can stabilize or improve vision.
Clinical trials are advancing new treatments for wet age-related macular degeneration. Currently, 1 studies are recruiting a combined 15 participants across the United States. Research is being conducted by 1 organizations including Adverum Biotechnologies, Inc..
2026 Wet Age-Related Macular Degeneration Research Landscape
As of July 2026, the wet age-related macular degeneration clinical trial landscape includes 1 actively recruiting studies across 4 cities in the United States. These studies are collectively seeking 15 participants, with an average enrollment target of 15 per study.
The research spans multiple phases of development: 1 study is in PHASE2.
Research is being led by 1 organization, including Adverum Biotechnologies, Inc..
Geographically, wet age-related macular degeneration trials are most concentrated in Deerfield Beach, Florida (1 trial); Fort Lauderdale, Florida (1 trial); Jacksonville, Florida (1 trial); West Columbia, South Carolina (1 trial).
Featured Wet Age-Related Macular Degeneration Studies
Highlighted recruiting studies for wet age-related macular degeneration, selected by enrollment size and research scope.
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
The purpose of this study is to evaluate safety, effectiveness and durability of a gene therapy called Ixo-vec (Ixoberogene soroparvovec) when administered to the contralateral (second) eye of adult participants (≥ 50 years of age) who have been diagnosed with bilateral neovascular (wet) age related macular degeneration (nAMD). The study will enroll adults with nAMD in both eyes, including partici...
Frequently Asked Questions About Wet Age-Related Macular Degeneration Clinical Trials
Are there wet age-related macular degeneration clinical trials near me?
Yes, there are 1 wet age-related macular degeneration clinical trials currently recruiting across 4+ cities in the United States, including Deerfield Beach, Florida; Fort Lauderdale, Florida; Jacksonville, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a wet age-related macular degeneration clinical trial?
To join a wet age-related macular degeneration clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are wet age-related macular degeneration clinical trials free?
Yes, participation in wet age-related macular degeneration clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of wet age-related macular degeneration treatments are being studied?
Current wet age-related macular degeneration clinical trials are testing a range of approaches across PHASE2 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in wet age-related macular degeneration clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov